BeiGene
ONC
#728
Rank
C$37.19 B
Marketcap
$319.81
Share price
1.24%
Change (1 day)
76.01%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

We have found no dividend yield history for this company